Morphological reversion of sis-transformed NIH3T3 cells by trichostatin A.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1727377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular themes in oncogenesis.

  1991cited by this paper
• Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras.

  1990cited by this paper
• Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

  1990cited by this paper
• Permanent conversion of NIH3T3 cells transformed by activated c-Ha-ras, c-Ki-ras, N-ras, or c-raf, and of human pancreatic adenocarcinoma containing activated c-Ki-ras to apparently normal cells by treatment with the antibiotic azatyrosine.

  1990cited by this paper
• Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells.

  1989cited by this paper
• Sodium butyrate suppresses the transforming activity of an activated N-ras oncogene in human colon carcinoma cells.

  1989cited by this paper
• Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin

  1989cited by this paper
• Flat reversion by okadaic acid of raf and ret-II transformants.

  1989cited by this paper
• Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A.

  1988cited by this paper
• A direct link between core histone acetylation and transcriptionally active chromatin.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Dimethyl sulfoxide-inducible cytoplasmic factor involved in erythroid differentiation in mouse erythroleukemia (Friend) cells.

  1987cited by this paper
• Rapid and reversible changes in nucleosome structure accompany the activation, repression, and superinduction of murine fibroblast protooncogenes c-fos and c-myc.

  1987cited by this paper
• Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine

  1987cited by this paper
• Affinity chromatographic purification of nucleosomes containing transcriptionally active DNA sequences.

  1987cited by this paper
• Effects of trichostatins on differentiation of murine erythroleukemia cells.

  1987cited by this paper
• Basic methods in molecular biology

  1986cited by this paper
• cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines

  1986cited by this paper
• A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains

  1986cited by this paper
• Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.

  1986cited by this paper
• A specific inhibitor for tyrosine protein kinase from Pseudomonas.

  1986cited by this paper
• An intracellular factor that induces erythroid differentiation in mouse erythroleukemia (Friend) cells.

  1986cited by this paper
• Viral oncogenes.

  1985cited by this paper
• Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.

  1985cited by this paper
• Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.

  1984cited by this paper
• Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor

  1983cited by this paper
• Suramin: with special reference to onchocerciasis.

  1978cited by this paper
• n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells

  1977cited by this paper
• A new antifungal antibiotic, trichostatin.

  1976cited by this paper
• A new group of potent inducers of differentiation in murine erythroleukemia cells.

  1976cited by this paper
• Patterns of organization of actin and myosin in normal and transformed cultured cells.

  1975cited by this paper
• Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells.

  1975cited by this paper
• Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

  1971cited by this paper
• A NEW ANTIFUNGAL ANTIBIOTIC.

  1964cited by this paper

• Green one-pot synthesis of quinoxaline derivatives using sulfo-anthranilic acid functionalized alginate-MCFe2O4 nanostructures: a novel superparamagnetic catalyst with antiproliferative potential

  2025cites this paper
• Advances in Treatment of Diffuse Midline Gliomas

  2023cites this paper
• Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomics.

  2021cites this paper
• Establishing a quick screening method by using a microfluidic chip to evaluate cytotoxicity of metal contaminants.

  2019cites this paper
• Bioprobes at a Glance

  2017cites this paper
• A chemical probe toolbox for dissecting the cancer epigenome

  2017cites this paper
• Use microfluidic chips to study the effects of ultraviolet lights on human fibroblasts

  2017cites this paper
• The Effect of Histone Hyperacetylation on Viability of Basal-Like Breast Cancer Cells MDA-MB-231

  2017cites this paper
• Use microfluidic chips to study the effects of ultraviolet lights on human fibroblasts

  2017cites this paper
• Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells

  2016cites this paper
• Screening Strategies for Drug Discovery and Target Identification

  2015cites this paper
• Histone modifications: Targeting head and neck cancer stem cells.

  2014cites this paper
• Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer

  2013cites this paper
• The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.

  2012cites this paper
• Current advances in non-proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myeloma.

  2011cites this paper
• Deacetylation of nonhistone proteins by HDACs and the implications in cancer.

  2011cites this paper
• Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.

  2009cites this paper
• Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.

  2008cites this paper
• Histone deacetylase inhibitors from microorganisms: the Astellas experience.

  2008cites this paper
• A Phase II Clinical Trial of Oral Valproic Acid in Patients with Castration-Resistant Prostate Cancers Using an Intensive Biomarker Sampling Strategy.

  2008cites this paper
• Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.

  2008cites this paper
• Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells

  2006cites this paper
• The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.

  2004cites this paper
• Participation of p97Eps8 in Src-mediated Transformation*

  2004cites this paper
• Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors*

  2003cites this paper
• Growth inhibition by the mammalian SWI–SNF subunit Brm is regulated by acetylation

  2003cites this paper
• Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.

  2003cites this paper
• Trichostatin A-induced Detransformation Correlates with Decreased Focal Adhesion Kinase Phosphorylation at Tyrosine 861 inras-transformed Fibroblasts*

  2002cites this paper
• Requirement for RAR-mediated gene repression in skeletal progenitor differentiation

  2002cites this paper
• Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor.

  2002cites this paper
• Role of Histone Deacetylation in Developmentally Programmed DNA Rearrangements in Tetrahymena thermophila

  2002cites this paper
• Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype.

  2000cites this paper
• Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

  1999cites this paper
• Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.

  1999cites this paper
• Antitumor Efficacy of Hypothemycin, A New Ras‐signaling Inhibitor

  1999cites this paper
• Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

  1999cites this paper
• A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

  1999cites this paper
• Suppression of oncogenic transformation by hypothemycin associated with accelerated cyclin D1 degradation through ubiquitin-proteasome pathway.

  1999cites this paper
• Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects*

  1999cites this paper
• Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.

  1998cites this paper
• FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

  1998cites this paper
• Histone acetylation: chromatin in action.

  1997cites this paper
• Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo.

  1997cites this paper
• Identification of mouse histone deacetylase 1 as a growth factor-inducible gene

  1997cites this paper
• Suppression of morphological transformation by radicicol is accompanied by enhanced gelsolin expression

  1997cites this paper
• Mammals II: Downstream of RAS and Actin-Cytoskeleton

  1996cites this paper
• Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase.

  1996cites this paper
• Image analysis detects lineage-specific morphologic markers in leukemic blast cells.

  1996cites this paper
• Histone hyperacetylating agents stimulate promoter activity of human choline acetyltransferase gene in transfection experiment.

  1996cites this paper
• Modulation of growth and differentiation of human colon carcinoma cells by histone deacetylase inhibitory trichostatins.

  1996cites this paper
• Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function

  1995cites this paper
• Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells.

  1995cites this paper
• A novel styryl diphenylamine derivative reverts the transformed phenotype of human fibrosarcoma HT1080 cells.

  1995cites this paper
• Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines.

  1994cites this paper
• Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

  1993cites this paper
• Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.

  1993cites this paper
• A Novel Tetracyclic Peptide, Trapoxin, Induces Phenotypic Change from Transformed to Normal in sis‐Oncogene‐transformed NIH3T3 Cells

  1992cites this paper